JP2003532409A5 - - Google Patents

Download PDF

Info

Publication number
JP2003532409A5
JP2003532409A5 JP2001582397A JP2001582397A JP2003532409A5 JP 2003532409 A5 JP2003532409 A5 JP 2003532409A5 JP 2001582397 A JP2001582397 A JP 2001582397A JP 2001582397 A JP2001582397 A JP 2001582397A JP 2003532409 A5 JP2003532409 A5 JP 2003532409A5
Authority
JP
Japan
Prior art keywords
variable region
antigen
human
dendritic cells
chain variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001582397A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003532409A (ja
JP5007409B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/015114 external-priority patent/WO2001085798A2/en
Publication of JP2003532409A publication Critical patent/JP2003532409A/ja
Publication of JP2003532409A5 publication Critical patent/JP2003532409A5/ja
Application granted granted Critical
Publication of JP5007409B2 publication Critical patent/JP5007409B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001582397A 2000-05-08 2001-05-08 樹状細胞に対するヒトモノクローナル抗体 Expired - Fee Related JP5007409B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20312600P 2000-05-08 2000-05-08
US60/203,126 2000-05-08
US23073900P 2000-09-07 2000-09-07
US60/230,739 2000-09-07
PCT/US2001/015114 WO2001085798A2 (en) 2000-05-08 2001-05-08 Human monoclonal antibodies to dendritic cells

Publications (3)

Publication Number Publication Date
JP2003532409A JP2003532409A (ja) 2003-11-05
JP2003532409A5 true JP2003532409A5 (https=) 2008-06-19
JP5007409B2 JP5007409B2 (ja) 2012-08-22

Family

ID=26898333

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001582397A Expired - Fee Related JP5007409B2 (ja) 2000-05-08 2001-05-08 樹状細胞に対するヒトモノクローナル抗体

Country Status (13)

Country Link
US (1) US7563876B2 (https=)
EP (1) EP1282646B1 (https=)
JP (1) JP5007409B2 (https=)
KR (2) KR100881471B1 (https=)
CN (1) CN1452636B (https=)
AT (1) ATE553131T1 (https=)
AU (2) AU6138301A (https=)
CA (1) CA2408594A1 (https=)
DK (1) DK1282646T3 (https=)
IL (2) IL152652A0 (https=)
MX (1) MXPA02010869A (https=)
NZ (1) NZ534864A (https=)
WO (1) WO2001085798A2 (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100881471B1 (ko) 2000-05-08 2009-02-05 셀덱스 쎄라퓨틱스, 인크. 수상세포에 대한 인간 모노클로날 항체
US7560534B2 (en) 2000-05-08 2009-07-14 Celldex Research Corporation Molecular conjugates comprising human monoclonal antibodies to dendritic cells
US20060222633A1 (en) * 2000-05-11 2006-10-05 Yale University Prevention, decrease, and/or treatment of immunoreactivity by depleting and/or inactivating antigen presenting cells in the host
US7754208B2 (en) 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
NZ527977A (en) 2001-02-12 2005-10-28 Medarex Inc Human monoclonal antibodies to FC alpha receptor (CD89)
JP5355839B2 (ja) 2001-10-23 2013-11-27 ピーエスエムエー デベロプメント カンパニー， エル．エル．シー． Ｐｓｍａ抗体およびタンパク質マルチマー
US20050215472A1 (en) 2001-10-23 2005-09-29 Psma Development Company, Llc PSMA formulations and uses thereof
US9259459B2 (en) 2003-01-31 2016-02-16 Celldex Therapeutics Inc. Antibody vaccine conjugates and uses therefor
ATE552860T1 (de) * 2003-01-31 2012-04-15 Celldex Res Corp Antikörper-vakzine-konjugate und ihre verwendungen
CA2566473A1 (en) * 2004-05-17 2005-12-08 Board Of Trustees Of The University Of Illinois Uses of bispecific antibody (biab) coated dendritic cells pulsed with antigens
WO2006073921A2 (en) * 2004-12-30 2006-07-13 The Rockefeller University Compositions and methods for enhanced dendritic cell maturation and function
RU2423381C2 (ru) 2005-07-25 2011-07-10 Трабьон Фармасьютикалз, Инк. Снижение количества в-клеток с использованием cd37-специфических и cd20-специфических связывающих молекул
NZ573646A (en) 2006-06-12 2012-04-27 Wyeth Llc Single-chain multivalent binding proteins with effector function
JP2008029319A (ja) * 2006-06-28 2008-02-14 Yoichiro Iwakura 樹状細胞免疫受容体遺伝子ノックアウト疾患モデル動物
CN101888856B (zh) 2007-11-07 2014-08-27 塞尔德克斯医疗公司 结合人树突和上皮细胞205(dec-205)的抗体
RU2531754C2 (ru) 2008-04-11 2014-10-27 ЭМЕРДЖЕНТ ПРОДАКТ ДИВЕЛОПМЕНТ СИЭТЛ,ЭлЭлСи,US Связывающееся с cd37 иммунотерапевтическое средство и его комбинация с бифункциональным химиотерапевтическим средством
AU2011207189B2 (en) 2008-08-08 2014-01-16 Immunomedics, Inc. Detection of early-stage pancreatic adenocarcinoma
CN102186499B (zh) * 2008-08-20 2015-05-20 Ibc医药公司 用于癌症治疗的对接和锁定(dnl)疫苗
EP2326350B1 (en) 2008-09-08 2013-09-04 Psma Development Company, L.L.C. Compounds for killing psma-expressing, taxane-resistant cancer cells
DK2406289T3 (en) 2009-03-10 2017-05-01 Baylor Res Inst ANTIGEN PRESENTING CELL TARGETED ANTIVIRUS VACCINES
AU2010222942B2 (en) 2009-03-10 2013-01-10 Baylor Research Institute Anti-CD40 antibodies and uses thereof
EP2477655A4 (en) 2009-09-14 2014-02-12 Baylor Res Inst VACCINES TREATED ON LANGERHANS CELLS
ES2709654T3 (es) 2011-04-29 2019-04-17 Apexigen Inc Anticuerpos anti-CD40 y métodos de uso
CA2850572A1 (en) * 2011-10-20 2013-04-25 Esbatech, A Novartis Company Llc Stable multiple antigen-binding antibody
US20150299315A1 (en) * 2012-10-22 2015-10-22 Becton, Dickinson And Company Non-b-lineage cells capable of producing antibody
KR102270618B1 (ko) 2012-10-30 2021-06-30 아펙시젠, 인코포레이티드 항-cd40 항체 및 사용 방법
CN120939216A (zh) 2014-01-13 2025-11-14 贝勒研究院 抗hpv和hpv相关的疾病的新疫苗
WO2017053469A2 (en) 2015-09-21 2017-03-30 Aptevo Research And Development Llc Cd3 binding polypeptides
US10610585B2 (en) 2017-09-26 2020-04-07 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and compositions for treating and preventing HIV
MX2021003866A (es) 2018-10-05 2021-09-08 Xenotherapeutics Inc Productos y metodos de xenotransplante.
US10883084B2 (en) 2018-10-05 2021-01-05 Xenotherapeutics, Inc. Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same
CN113429481B (zh) * 2021-07-07 2022-05-31 江苏农牧科技职业学院 一种靶向树突状细胞的纳米抗体分子及应用
WO2023070317A1 (zh) * 2021-10-26 2023-05-04 江苏省农业科学院 基于dc细胞的双功能纳米抗体及其构建方法和应用

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865689A (en) * 1972-11-09 1975-02-11 Hoffmann La Roche Method of producing carcinoembryonic antigens
US4446122A (en) * 1979-12-28 1984-05-01 Research Corporation Purified human prostate antigen
US4331647A (en) * 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5053224A (en) * 1983-11-07 1991-10-01 Hilary Koprowski Induction of antibody response to solid tumors with anti-idiotype antibodies
MX9203291A (es) 1985-06-26 1992-08-01 Liposome Co Inc Metodo para acoplamiento de liposomas.
US4954617A (en) * 1986-07-07 1990-09-04 Trustees Of Dartmouth College Monoclonal antibodies to FC receptors for immunoglobulin G on human mononuclear phagocytes
US5260203A (en) * 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
NZ222509A (en) * 1986-11-19 1993-03-26 Oncogen Hybridoma cell line producing antibodies binding to tumour-associated mucin antigen
US5683674A (en) * 1987-01-07 1997-11-04 Imperial Cancer Research Technology Ltd. Antibody against human mucin core protein and method of preparing and using same
ATE243754T1 (de) * 1987-05-21 2003-07-15 Micromet Ag Multifunktionelle proteine mit vorbestimmter zielsetzung
GB8823869D0 (en) * 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5108921A (en) 1989-04-03 1992-04-28 Purdue Research Foundation Method for enhanced transmembrane transport of exogenous molecules
AU656716B2 (en) * 1989-09-15 1995-02-16 Genetic Systems Corporation Hybridoma CT43 producing a monoclonal antibody to a mucin epitope of colorectal cancer
US5165922A (en) * 1990-05-22 1992-11-24 Bristol-Myers Squibb Company Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy
AU9040591A (en) 1990-11-06 1992-05-26 Children's Medical Center Corporation Soluble mannose receptor peptides
GB9117522D0 (en) 1991-08-14 1991-10-02 Medical Res Council Ligands for dendritic cells, their uses and production
DE4133791A1 (de) * 1991-10-11 1993-04-15 Behringwerke Ag Monoklonale antikoerper gegen tumorassoziierte antigene, verfahren zu ihrer herstellung und ihre verwendung
AU8068694A (en) * 1993-11-04 1995-05-23 Canterbury Health Limited Dendritic cell-specific antibodies and methods for their preparation
WO1995015340A1 (en) 1993-12-03 1995-06-08 The Board Of Trustees Of Leland Stanford Junior University Monoclonal antibodies to antigens expressed by human dendritic cells
US20020187131A1 (en) * 1995-01-31 2002-12-12 Daniel Hawiger Enhanced antigen delivery and modulation of the immune response therefrom
JPH10513350A (ja) 1995-01-31 1998-12-22 ザ ロックフェラー ユニヴァーシティ ＤＥＣ（樹状細胞及び上皮細胞、２０５ ｋＤａ）の同定、Ｃ型レクチンドメインを有するレセプター、ＤＥＣをコードする核酸、及びこれらの使用
US5773292A (en) * 1995-06-05 1998-06-30 Cornell University Antibodies binding portions, and probes recognizing an antigen of prostate epithelial cells but not antigens circulating in the blood
US5869057A (en) * 1995-06-07 1999-02-09 Rock; Edwin P. Recombinant vaccines to break self-tolerance
US6080409A (en) * 1995-12-28 2000-06-27 Dendreon Corporation Immunostimulatory method
JP2000512490A (ja) 1996-05-29 2000-09-26 デレク ナイジェル ジョン ハート 樹状細胞のレセプター
US5922845A (en) * 1996-07-11 1999-07-13 Medarex, Inc. Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
WO1998015579A1 (en) * 1996-10-09 1998-04-16 Canterbury Health Limited Dendritic cell-specific antibodies
KR20010021597A (ko) * 1997-07-09 2001-03-15 둘락 노먼 씨. 분리된 덴드라이틱 세포막 단백질 유전자
EP1027063B1 (en) 1997-09-29 2009-02-18 The Macfarlane Burnet Institute For Medical Research And Public Health Ltd Mannose receptor bearing cell line and antigen composition
WO1999024554A2 (en) 1997-11-12 1999-05-20 University Of Pittsburgh Isolation, characterization, and identification of dendritic like cells and methods of using same
CA2323083A1 (en) 1998-03-17 1999-09-23 Schering Corporation Isolated mammalian membrane protein genes and related reagents
ES2230848T3 (es) 1998-04-28 2005-05-01 Smithkline Beecham Corporation Anticuerpos monoclonales con inmunogenicidad reducida.
EP1078060B1 (en) 1998-05-11 2007-01-10 E.P. Prof. Dr. Rieber Antibodies to dendritic cells and human dendritic cell populations and uses thereof
AU4954899A (en) 1998-06-26 2000-01-17 Trustees Of Dartmouth College Methods and compositions for modulating antigen-specific immunological (humoral)responses by targeting such antigen to apcs in conjunction with anti-cd40 ligan d administration
KR100295558B1 (ko) 1998-06-27 2001-07-12 김기태 1차면역세포들중덴드리틱세포(dendriticcell)표면에특이하게작용하는단클론항체3-6-a
EP0997476A3 (en) 1998-09-25 2000-07-19 Schering-Plough Antibodies to a mammalian Langerhans cell antigen and their uses
EP1046651A1 (en) * 1999-04-19 2000-10-25 Koninklijke Universiteit Nijmegen Composition and method for modulating dendritic cell-T interaction
KR100881471B1 (ko) 2000-05-08 2009-02-05 셀덱스 쎄라퓨틱스, 인크. 수상세포에 대한 인간 모노클로날 항체

Similar Documents

Publication Publication Date Title
JP2003532409A5 (https=)
US11981733B2 (en) LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereof
US20230303718A1 (en) Modified Antibody
JP2008543339A5 (https=)
KR100483494B1 (ko) 감마 인터페론에 대한 인간화 항체
JP3665316B2 (ja) 抗ｔｒａｉｌ−ｒ抗体
CN1518458B (zh) 移植物排斥反应抑制剂
JP2020528768A5 (https=)
JP2005508176A5 (https=)
KR20210032311A (ko) Cd19에 결합하는 중쇄 항체
JP2012526558A5 (https=)
CZ292295B6 (cs) Rekombinantní protilátková molekula, DNA sekvence, terapeutická nebo diagnostická kompozice a použití protilátkové molekuly
RU2011110169A (ru) Антитела против ccr2
CN1344275A (zh) 用淀粉样蛋白抗体除去淀粉样蛋白的方法
HRP20120701T1 (hr) Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1
CN111683966A (zh) 与cd22结合的重链抗体
JP2010509931A5 (https=)
TW200416044A (en) Humanized anti-lymphotoxin β receptor antibodies
Couto et al. Anti-BA46 monoclonal antibody Mc3: humanization using a novel positional consensus and in vivo and in vitro characterization
JP2022523360A5 (https=)
CN121263449A (zh) Cd19/cd38多特异性抗体
CN104829716A (zh) 用于治疗疾病的抗人sema4A抗体
US20030180799A1 (en) Antibodies against plasma cells
KR100250832B1 (ko) 비형 간염 바이러스의 표면 항원 프리-에스1 에피토프를 인식하는 생쥐 단일클론항체의 가변 영역,이를 암호하는 유전자 및 그의 염기 서열
WO2023232023A1 (en) Molecules binding pd-l1 and uses thereof